Pharma Giant Merck Acquires Prometheus for Nearly $11 Billion
[ad_1] Last Updated: April 17, 2023, 05:47 IST Merck’s financial results were better than expected in the fourth quarter of 2022 thanks in part to strong sales of its cancer drugs. (Image: Reuters) Prometheus’s share price was at $114.01 when the New York Stock Exchange closed on Friday Pharmaceutical giant Merck announced Sunday the purchase … Read more